Latest News- POC Haematology Diagnostics Market: Consumables is expected to lead the Product segment during 2025-2029

The POC Haematology Diagnostics Market is being driven by Increasing prevalence of blood disorders and infectious disease

The POC Haematology Diagnostics Market is expected to grow at a CAGR of 13.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 5786.8 million. In the POC Haematology Diagnostics Market, online marketing platforms, such as CLIA waived and eBay, are increasingly adopted by mid-sized and small-scale companies to expand their reach and offer a diverse range of products to end-users. Online marketing strategies enable businesses to minimize operational costs by eliminating the need for physical sales offices, recruitment of sales forces, and traditional distribution channels. Notable companies like Abbott and Sysmex are capitalizing on this trend, prioritizing online sales due to the escalating demand for POC haematology diagnostics. For customers, purchasing online provides numerous advantages, including convenience, seamless payment processing, discounts, and the ability to compare various product offerings effectively. 

Get more information on POC Haematology Diagnostics Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Consumables
  • Systems
• End-user
  • Hospitals and clinics
  • Homecare settings
  • Clinical diagnostic laboratories
• Application
  • Complete blood count
  • Hemoglobin testing
  • Glucose and coagulation tests
  • Others
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing prevalence of blood disorders and infectious disease
• Increasing growth in POC hematology diagnostics product launches
• Paradigm shift from benchtop to portable hematology diagnostic systems

However, the market also witnesses some limitations, which are as follows:

• High cost of hematology diagnostic products
• Efficacy issues of POC hematology diagnostics products
• Product recalls due to stringent regulations

Benefits of Buying Global POC Haematology Diagnostics Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in POC Haematology Diagnostics Market Research Report

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

Point-of-Care (POC) Haematology Diagnostics refers to rapid and near-patient testing solutions that enable real-time analysis of blood samples for various haematological conditions. These diagnostics, including home testing and multiplex testing, employ advanced technologies such as enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), real-time PCR, next-generation sequencing, gene expression profiling, and microarray analysis. Data management, quality assurance, and regulatory compliance are crucial aspects of POC Haematology Diagnostics, ensuring evidence-based medicine, personalized healthcare, patient engagement, and empowerment, ultimately contributing to improved health outcomes, disease prevention, early detection, and effective treatment monitoring.

Market Research Overview

The POC Haematology Diagnostics Market is a segment of the larger Global Healthcare Equipment Market, as identified by Technavio. This market encompasses companies and products involved in the research and development (R&D) of hematology analyzers and point-of-care (POC) testing for blood cell counting, complete blood count (CBC) analysis, differential count, platelet count, mean corpuscular volume (MCV), and mean corpuscular hemoglobin (MCH) analysis. The Global Healthcare Equipment Market size is determined by the combined revenue generated by manufacturers of various diagnostic equipment and devices used across therapy areas. The healthcare equipment industry consists of several segments, including Devices, which covers advanced, differentiated, and clinically tested data-driven devices, such as hematology analyzers.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/